Observational studyBMC ophthalmology2020

A 12-month, prospective, observational study of ranibizumab in treatment-naïve Taiwanese patients with neovascular age-related macular degeneration: the RACER study.

Wen-Chuan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.